Fred Telling - Jul 29, 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Stock symbol
OGEN
Transactions as of
Jul 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/2/2022, 04:35 PM
Previous filing
Jun 27, 2022
Next filing
Aug 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Non-Employee Director Option (Right to Buy) Award $0 +220K $0.00 220K Jul 29, 2022 Common Stock 220K $0.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.